Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody

Catalog No. ABIN7538074

The Humanized Chimeric anti-FCGRT (Rozanolixizumab Biosimilar) antibody (ABIN7538074) specifically detects FCGRT (Rozanolixizumab Biosimilar) in ELISA and WB. The antibody is reactive with Human samples.

Quick Overview for Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody (ABIN7538074)

Target: FCGRT (Rozanolixizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This FCGRT (Rozanolixizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-FCGRT (Rozanolixizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for FCGRT (Rozanolixizumab Biosimilar)

Target: FCGRT (Rozanolixizumab Biosimilar)

Target Type: Biosimilar

Background: Rozanolixizumab, a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases.

CAS-No: 1584645-37-3